+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibody Production"

Monoclonal Antibody Markets in China - Product Thumbnail Image

Monoclonal Antibody Markets in China

  • Report
  • November 2023
  • 219 Pages
  • China
From
Monoclonal Antibody Industry Forecasts - China Focus - Product Thumbnail Image

Monoclonal Antibody Industry Forecasts - China Focus

  • Report
  • November 2023
  • 92 Pages
  • China
From
From
From
From
From
From
From
From
Monoclonal Antibody Companies in China - Product Thumbnail Image

Monoclonal Antibody Companies in China

  • Report
  • November 2023
  • 73 Pages
  • China
From
From
From
Global Custom Antibody Market Report and Forecast 2024-2032 - Product Thumbnail Image

Global Custom Antibody Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 140 Pages
  • Global
From
Loading Indicator

The Antibody Production market is a segment of the biopharmaceutical industry that focuses on the production of antibodies for therapeutic and diagnostic purposes. Antibodies are proteins that are produced by the immune system to recognize and bind to specific antigens, such as bacteria and viruses. Antibody production involves the use of recombinant DNA technology to produce large quantities of antibodies for use in research, diagnostics, and therapeutics. The market is driven by the increasing demand for biopharmaceuticals, as well as the development of new technologies and techniques for producing antibodies. The Antibody Production market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more